SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED

Press Releases Shandong Xinhua Pharmaceutical Company Limited Shenzhen S.E.

Equities

000756

CNE000000BG1

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 14/05/2024 BST			5-day change	1st Jan Change
16.63 ^CNY	-1.89%		-4.15%	-18.40%

04-25	Shandong Xinhua Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-11	Xinhua Pharma Unit's Cefaclor Capsules Passes Regulatory Evaluation	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Shandong Xinhua Pharmaceutical : Announcement In Relation To Delay In Despatch Of Circular	03/05/21	PU
Shandong Xinhua Pharmaceutical : Appointment of Independent Financial Adviser	20/04/21	PU
Shandong Xinhua Pharmaceutical : Overseas Regulatory Announcement	14/04/21	PU
Shandong Xinhua Pharmaceutical : (1)Proposed Non-public Issuance of New a Shares;(2)Connected Transaction;(3)Application for Whitewash Waiver;and (4)Proposed Amendments to Articles of Association	14/04/21	PU
Shandong Xinhua Pharmaceutical : Unaudited First Quarter Results of 2021	09/04/21	PU
Shandong Xinhua Pharmaceutical : Continuing Connected Transactions In Relation To Shandong Lukang Agreement and China Shandong Agreement	30/03/21	PU
Shandong Xinhua Pharmaceutical : Proposed Amendments of the Articles of Association	30/03/21	PU
Shandong Xinhua Pharmaceutical : Announcement for 2020 Annual Results	30/03/21	PU
Shandong Xinhua Pharmaceutical : Announcement Notice of Board Meeting	26/03/21	PU
Shandong Xinhua Pharmaceutical : Announcement Notice of Board Meeting	18/03/21	PU
Shandong Xinhua Pharmaceutical : Overseas Regulatory Announcement	08/03/21	PU
Shandong Xinhua Pharmaceutical : Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2021	01/03/21	PU
Shandong Xinhua Pharmaceutical : Overseas Regulatory Announcement	21/09/20	PU
Shandong Xinhua Pharmaceutical : Terms of Reference of the Audit Committee under the Board of Directors	21/08/20	PU
Shandong Xinhua Pharmaceutical : Terms of Reference of the Nomination Committee under the Board of Directors	21/08/20	PU
Shandong Xinhua Pharmaceutical : Terms of Reference of the Remuneration and Appraisal Committee under the Board of Directors	21/08/20	PU
Shandong Xinhua Pharmaceutical : Supplemental Announcement In Relation To Continuing Connected Transaction	30/06/20	PU
Shandong Xinhua Pharmaceutical : Announcement Notice of Board Meeting	10/03/20	PU
Shandong Xinhua Pharmaceutical : FURTHER INCREASE IN SHAREHOLDING BY A CONTROLLING SHAREHOLDER	20/11/19	PU
Shandong Xinhua Pharmaceutical : UNAUDITED QUARTERLY RESULTS ANNOUNCEMENT FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2019	28/10/19	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Shandong Xinhua Pharmaceutical Company Limited Shenzhen S.E.

Equities

000756

CNE000000BG1

Press Releases

Filters